Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.62 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Ethylhexanoic Acid SCHEMBL31730242 | 0.92 | CA2 (0.75) | CA2DNM1CYP3A4TSHRNFKB1 | |
| 2-Ethylhexanoic Acid SCHEMBL17453704 | 0.92 | CA2 (0.75) | CA2DNM1CYP3A4TSHRNFKB1 | |
| 2-Ethylhexanoic Acid SCHEMBL230713 | 0.86 | CA2 (0.84) | CA2DNM1CYP3A4TSHRNFKB1 | |
| Bicarbonate SCHEMBL28469661 | 0.85 | DNM1 (0.67) | CA2DNM1NFKB1CA1GPR84 | |
| SCHEMBL17839035 | 0.83 | DNM1 (0.58) | CA2DNM1CYP3A4TSHRNFKB1 | |
| Acetic Acid SCHEMBL1032589 | 0.83 | DNM1 (0.64) | CA2DNM1NFKB1CA1GPR84 | |
| Acetic Acid SCHEMBL17839027 | 0.83 | DNM1 (0.64) | CA2DNM1NFKB1CA1GPR84 | |
| Acetic Acid SCHEMBL7929478 | 0.83 | DNM1 (0.64) | CA2DNM1NFKB1CA1GPR84 | |
| Acetic Acid SCHEMBL1036903 | 0.83 | DNM1 (0.64) | CA2DNM1NFKB1CA1GPR84 | |
| Oxalic Acid SCHEMBL11422811 | 0.83 | DNM1 (0.64) | CA2DNM1CA1GPR84CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233872-B1 | QUATERNARY CARBOXYLATE COMPOSITIONS FOR EXTRACTING C1 TO C4 CARBOXYLIC ACIDS FROM AQUEOUS STREAMS | EASTMAN CHEM CO (US) | 2019-10-30 | — | — | EP | disclosed |
| US-9573078-B2 | Quaternary carboxylate compositions for extracting C1 to C4 carboxylic acids from aqueous streams | EASTMAN CHEMICAL COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160175737-A1 | Quaternary Carboxylate Compositions for Extracting C1 to C4 Carboxylic Acids from Aqueous Streams | EASTMAN CHEMICAL COMPANY (US) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160175737-A1 | Quaternary Carboxylate Compositions for Extracting C1 to C4 Carboxylic Acids from Aqueous Streams | SLC16A3, CA4, SLC16A1 | CA2 21/4885DNM1 455/4885CYP3A4 1492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.